Therefore, the effects of abnormal SWI/SNF subunits (including the PBRM1 gene) and MSI on tumor immune activity may be both synergistic and independent, and the former may be another important factor leading to increased tumor immunity in addition to MSI-H. Here, PBRM1 is linked to neoplasm.